INmune Bio extends poison pill rights agreement to December 31, 2026

Inmune Bio, Inc.

Amendment No. 5 to Rights Agreement dated Dec 5, 2025 extends expiration to Dec 31, 2026.
Expiration date will auto-extend for successive one-year terms unless Board decides otherwise.
Rights Agreement originally dated Dec 30, 2020 between INmune Bio and VStock Transfer LLC.
No other changes to terms of the shareholder rights plan were disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.